Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Plant Health Care nematicide gets approval in Brazil
(Sharecast News) - Crop peptide specialist Plant Health Care announced on Tuesday that its nematicide product TEIKKO has received federal approval in Brazil, ahead of a commercial launch for the upcoming 2025 soybean growing season. The AIM-traded firm said TEIKKO, an innovative peptide product developed under its PREtec peptide platform, was designed to help farmers control nematode pests without resorting to traditional agrochemicals.
Nematodes are known to damage plant roots and limit crop yield, making their control essential for agricultural productivity.
Brazilian farmers face significant nematode-related challenges, spending over $200m on nematode control during the most recent season.
Research conducted during the 2022 and 2023 soybean crop seasons demonstrated that TEIKKO performed as well as or even outperformed standard agrochemical treatments for controlling root-lesion nematodes in soybeans.
Plant Health Care said TEIKKO offered several advantages over alternative biological products, including a three-year shelf-life, ease of storage, compatibility with other seed treatments, and reliable performance under various environmental conditions.
The company said it discussed introducing TEIKKO in 2024 with potential distribution partners, making it available for the 2025 soybean growing season.
"TEIKKO will help Brazilian farmers sustainably produce their soybean crops and supports the company's vision to be a leading global provider of alternatives to conventional agrochemicals," said chief executive officer Jeff Tweedy.
"Unlike TEIKKO, current soil fumigants and other chemical nematicides are known to have damaging off-target effects."
Tweedy described TEIKKO as an environmentally friendly biological alternative that performed as well as or better than older technologies, with the company expecting rapid adoption among Brazilian farmers.
"We are excited about the developing plans to launch TEIKKO in 2024, with strong growth thereafter."
At 1416 GMT, shares in Plant Health Care were up 6.78% at 3.94p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
